Periampullary Carcinoma Management

Diagnosis and Evaluation

• Ultrasound of the liver, bile duct, and pancreas should be performed without delay when periampullary cancer is suspected, and further evaluation with CT, ERCP, and/or MRI is recommended to accurately delineate tumor size, infiltration, and metastases, according to the European Society of Gastrointestinal Endoscopy 1
• Endosonography (EUS) is highly valuable for better characterization of small tumors, tissue sampling via fine needle aspiration, and assessment of vascular invasion, as recommended by the European Society of Gastrointestinal Endoscopy 1
• MRI with MRCP is the preferred imaging modality for further evaluation of a hypoechoic pancreatic mass found on ultrasound, with a sensitivity of 96.8% and specificity of 90.8% for distinguishing pancreatic cystic lesions, as recommended by the American College of Radiology 2
• The following table summarizes the sensitivity, specificity, and accuracy of different imaging modalities:

3, 4

• Evaluate for concerning clinical symptoms, including jaundice, abdominal or back pain, unexplained weight loss, new-onset diabetes, and history of pancreatitis, to determine the need for further testing 5, 2, 6
• Perform liver function tests (e.g., bilirubin, alkaline phosphatase, ALT, and AST) and pancreatic enzymes (e.g., amylase and lipase) to assess pancreatic function 5
• Measure tumor marker CA19-9, particularly if there are concerning imaging features, to evaluate for potential malignancy 5

Surgical Treatment

• Surgical resection is the only potentially curative treatment for periampullary carcinoma and should be performed at specialist centers to increase resection rates and reduce hospital morbidity and mortality, according to the European Society of Gastrointestinal Endoscopy 1
• Pancreaticoduodenectomy (Whipple procedure) is the most appropriate resectional procedure for tumors of the pancreatic head, and pylorus preservation may be considered based on tumor location, as recommended by the European Society of Gastrointestinal Endoscopy 1
• Left-sided resection (with splenectomy) is appropriate for localized carcinomas of the body and tail, and extended resections involving the portal vein may be required in select cases, according to the European Society of Gastrointestinal Endoscopy 1
• Radical surgery is the only curative treatment for pancreatic cancer, with surgical approach depending on tumor location, as recommended by the European Society of Gastrointestinal Endoscopy 5

Biliary and Duodenal Obstruction Management

• Endoscopic stent placement is preferable to trans-hepatic stenting, and plastic stents are adequate for most patients; surgical bypass may be preferred in patients likely to survive more than six months, as recommended by the European Society of Gastrointestinal Endoscopy 1
• Duodenal obstruction should be treated surgically with duodenal bypass, and biliary bypass should be constructed with the bile duct in preference to the gallbladder, according to the European Society of Gastrointestinal Endoscopy 1

Preoperative and Intraoperative Considerations

• Percutaneous biliary drainage prior to resection in jaundiced patients does not improve surgical outcome and may increase infection risk, and if stenting is required before surgery, use plastic stents placed endoscopically, as stated by the European Society of Gastrointestinal Endoscopy 1
• Jaundice in patients with carcinoma of the body or tail usually indicates inoperability due to hepatic or hilar metastases, according to the European Society of Gastrointestinal Endoscopy 1

Clinical Presentation and Prognosis

• Persistent back pain, severe and rapid weight loss, palpable and fixed epigastric mass, ascites, and enlarged supraclavicular lymph node (Virchow's node) are clinical presentations that may indicate periampullary carcinoma, as described by the European Society of Gastrointestinal Endoscopy 1
• Nausea and vomiting should be assessed at every outpatient visit and within 24 hours of inpatient admission, and refractory nausea/vomiting should be managed with antiemetics targeting multiple receptors, appetite stimulants, and nutritional consultation, as recommended by the National Comprehensive Cancer Network 7, 8
• Symptomatic ascites causing abdominal pressure should be treated with paracentesis, and malignant bowel obstruction should be assessed, particularly in advanced disease, as recommended by the National Comprehensive Cancer Network 7, 8
• Palliative care consultation should be considered for refractory symptoms, and regular reassessment of symptoms at each clinical encounter and adjustment of management based on disease progression and treatment response are crucial, as recommended by the National Comprehensive Cancer Network 7
• Depression and anxiety should be assessed, and patients should be considered for antidepressants, anxiolytics, or referral for psychological support, as recommended by the British Society of Gastroenterology 7

Surveillance and Follow-up

• If initial advanced imaging shows no concerning features, MRI surveillance should be performed after 1 year and then every 2 years, as recommended by the American Gastroenterological Association 9
• Consider discontinuing surveillance if no significant changes are seen after 5 years, as recommended by the American Gastroenterological Association 9